2026-2032 年微晶纤维素 (MCC) 市场（按原始材料类型、应用、最终用户和地区划分）

微晶纤维素（MCC）市场评估，2026-2032

微晶纤维素 (MCC) 市场因其在各行各业（尤其是製药、食品和化妆品）的广泛应用而需求显着增长。作为药物製剂中的关键辅料，MCC 因其优异的黏合性、崩坏和流动性而备受推崇，这些特性能够增强锭剂和胶囊的功效。随着医疗支出增加和慢性病盛行率上升，全球製药业的成长推动了对 MCC 的需求。预计 2024 年市场规模将超过 13.8 亿美元，到 2032 年将达到约 24.6 亿美元。

食品业正在将微晶纤维素 (MCC) 用作低热量和无麸质产品中的脂肪替代品和稳定剂，进一步促进了市场的成长。对经济高效情绪分析的需求日益增长，推动市场在 2026 年至 2032 年期间的复合年增长率达到 8.24%。

微晶纤维素（MCC）市场：定义/概述

微晶纤维素 (MCC) 是一种精製的、部分解聚合的纤维素，由植物纤维素水解而成。它呈白色无味粉末，具有高纯度、低密度和优异流动性等独特特性。 MCC 广泛用于製药、食品和化妆品行业，用作填充剂、粘合剂和稳定剂。在製药业，它可作为锭剂赋形剂，提高可压性并促进药物释放。在食品业，它可用作组织改质剂、脂肪替代品和填充剂，有助于提高各种产品的一致性和稳定性。

由于各行各业对天然和永续材料的需求日益增长，微晶纤维素被视为极具潜力的候选材料。随着消费者对健康和营养意识的不断提升，微晶纤维素在洁净标示产品配方中的应用前景广阔。奈米技术的创新或将推动基于微晶纤维素的奈米复合材料的开发，从而增强其在包装和药物传输系统等应用领域的功能性。生物技术的进步有望利用替代可再生资源生产微晶纤维素，进一步巩固其作为环保原料的地位。随着各行各业都在努力减少对环境的影响，微晶纤维素的生物分解性和可再生特性使其成为未来在健康、食品和材料科学领域应用的宝贵材料。

不断发展的製药业会推动微晶纤维素 (MCC) 市场的发展吗？

蓬勃发展的製药业将为微晶纤维素 (MCC) 市场提供强劲动力。製药业是 MCC 的主要消费领域，将其用作各种药物製剂的辅料。预计到 2026 年，全球药品支出将达到 1.8 兆美元，复合年增长率为 3-6%。製药业投资的不断增长不仅推动了对 MCC 的需求（MCC 在提高锭剂可压性、稳定性和生物有效性方面发挥着至关重要的作用），也凸显了在开发新型创新药物输送系统时对高品质辅料的需求。

加工食品和方便食品日益增长的需求是微晶纤维素 (MCC) 市场的主要驱动力。全球方便食品市场正在迅速扩张，2021 年市场规模达 5,137 亿美元，预计 2022 年至 2030 年的复合年增长率将达到 5.6%，因为消费者正在寻求快速易做的膳食选择。 MCC 作为质构剂和脂肪替代品，使其成为一种有价值的添加剂，能够改善加工食品的质地和稳定性，满足消费者对更健康、低脂食品的偏好，同时又不影响产品品质。人们对方便食品日益增长的偏好与 MCC 在食品配方中的使用量增加直接相关，从而推动了食品行业对这种用途广泛的配料的整体需求。

原料的可用性会影响微晶纤维素 (MCC) 市场的成长吗？

原料供应可能会阻碍微晶纤维素 (MCC) 市场的成长。 MCC 主要来自天然纤维素，例如木浆和植物纤维，但受气候变迁、森林砍伐以及其他产业对这些原材料的竞争等因素的影响，其供应量可能会出现波动。随着生产商越来越注重环保的采购和生产方式，对永续实践的需求不断增长，这可能会对高品质纤维素的供应造成压力。

由于食品和製药业对添加剂的使用受到严格监管，监管障碍可能会阻碍微晶纤维素 (MCC) 市场的成长。这些法规通常要求进行广泛的安全性和有效性评估，这可能会导致成本增加和产品核可时间延长。对于希望在全球销售 MCC 的製造商而言，不同地区的不同监管标准构成了挑战，使合规工作更加复杂。天然和洁净标示产品的趋势可能会促使监管机构调整其框架，以接纳像 MCC 这样安全有效的天然添加剂，从而提高其接受度并推动应用创新。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 微晶纤维素（MCC）市场（按原始材料类型）

• 非木质MCC
• 木质MCC

5. 微晶纤维素（MCC）市场应用

• 化妆品和个人护理
• 饮食
• 製药

6. 微晶纤维素（MCC）市场（依最终用户）

• 化妆品和个人护理行业
• 食品饮料业
• 製药业

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Wei Ming Pharmaceutical Co., Ltd.（China）
• Juku Orchem Private Limited（India）
• Sigachi（Japan）
• BLANVER（China）
• Anhui Sunhere Pharmaceutical Group Co., Ltd.（China）
• Roquette Freres（France）
• DuPont de Nemours, Inc.（US）
• Ashland Global Holdings Inc.（US）
• Borregaard ASA（Norway）
• Imerys SA（France）

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Microcrystalline Cellulose Market Valuation - 2026-2032

The microcrystalline cellulose (MCC) market is experiencing a significant increase in demand due to its versatile applications across various industries, particularly in pharmaceuticals, food, and cosmetics. As a crucial excipient in drug formulations, MCC is valued for its excellent binding, disintegration, and flow properties, which enhance the efficacy of tablets and capsules. The growing global pharmaceutical industry, driven by an increase in healthcare spending and the rising prevalence of chronic diseases, is propelling the demand for MCC. The market size surpass USD 1.38 Billion valued in 2024 to reach a valuation of around USD 2.46 Billion by 2032.

The food industry is embracing MCC as a fat replacer and a stabilizer in low-calorie and gluten-free products, further contributing to its market growth. The rising demand for cost-effective and efficient emotion analytics is enabling the market grow at a CAGR of 8.24% from 2026 to 2032.

Microcrystalline Cellulose Market: Definition/ Overview

Microcrystalline cellulose (MCC) is a purified, partially depolymerized cellulose obtained from plant cellulose sources through hydrolysis. It appears as a white, odorless powder and possesses unique properties such as high purity, low density, and excellent flowability. MCC is widely utilized in the pharmaceutical, food, and cosmetic industries as a filler, binder, and stabilizer. In pharmaceuticals, it serves as an excipient in tablet formulations, enhancing compressibility and aiding in drug release. In the food industry, it acts as a texturizing agent, fat replacer, and bulking agent, contributing to the consistency and stability of various products.

Microcrystalline cellulose looks promising, driven by the growing demand for natural and sustainable ingredients in various sectors. With increasing consumer awareness regarding health and nutrition, MCC's applications are likely to expand in the formulation of clean-label products. Innovations in nanotechnology may lead to the development of MCC-based nanocomposites, enhancing their functionality in applications like packaging and drug delivery systems. Advancements in biotechnology may enable the production of MCC from alternative, renewable sources, further solidifying its role as an eco-friendly ingredient. As industries seek to minimize their environmental impact, MCC's biodegradable and renewable characteristics position it as a valuable material for future applications in health, food, and materials science.

Will the Growing Pharmaceutical Industry Drive the Microcrystalline Cellulose Market?

The growing pharmaceutical industry is set to significantly fuel the microcrystalline cellulose (MCC) market. As the pharmaceutical sector is a major consumer of MCC, utilizing it as an excipient in various drug formulations, the projected global spending on medicines-expected to reach $1.8 trillion by 2026 with a compound annual growth rate (CAGR) of 3-6%-indicates a robust growth trajectory for the industry. This increasing investment in pharmaceuticals not only drives demand for MCC due to its essential roles in enhancing tablet compressibility, stability, and bioavailability but also highlights the need for high-quality excipients in the development of new and innovative drug delivery systems.

The increasing demand for processed and convenience foods will significantly fuel the microcrystalline cellulose (MCC) market. As consumers seek quick, easy-to-prepare meal options, the global convenience food market, valued at $513.7 billion in 2021 and projected to grow at a CAGR of 5.6% from 2022 to 2030, is expanding rapidly. MCC's role as a texturizing agent and fat replacer makes it a valuable additive in enhancing the texture and stability of processed foods, catering to consumer preferences for healthier, lower-fat options without compromising on quality. This growing inclination towards convenience foods directly correlates with the increased utilization of MCC in food formulations, driving the overall demand for this versatile ingredient in the food industry.

Will Raw Material Availability Impact the Growth of the Microcrystalline Cellulose Market?

Raw material availability could potentially hamper the growth of the microcrystalline cellulose (MCC) market. MCC is primarily derived from natural cellulose sources, such as wood pulp and plant fibers, which are subject to fluctuations in availability due to factors like climate change, deforestation, and competition with other industries for these raw materials. The rising demand for sustainable practices may strain the supply of high-quality cellulose, as producers increasingly focus on eco-friendly sourcing and production methods.

Regulatory hurdles may hamper the growth of the microcrystalline cellulose (MCC) market, as the food and pharmaceutical industries are subject to stringent regulations regarding the use of additives. These regulations often require extensive safety and efficacy evaluations, which can lead to increased costs and extended timelines for product approvals. Varying regulatory standards across different regions can create challenges for manufacturers looking to market MCC globally, complicating compliance efforts, the trend towards natural and clean-label products may push regulatory bodies to adapt their frameworks to accommodate safe and effective natural additives like MCC, potentially facilitating its acceptance and encouraging innovation in its applications.

Category-Wise Acumens

Will High Purity and Consistency Propel the Non-Wood Based MCC Segment for the Microcrystalline Cellulose Market?

Non-Wood Based MCC Segment is dominating the microcrystalline cellulose market. High purity and consistency are key factors propelling the non-wood-based microcrystalline cellulose (MCC) segment in the microcrystalline cellulose market. As industries increasingly prioritize quality and safety, the demand for MCC with high purity levels becomes critical, especially in pharmaceuticals, food, and cosmetics, where contaminants can significantly impact product efficacy and consumer safety. Non-wood sources, such as cotton and certain plant fibers, offer a more consistent and controllable production process, resulting in a higher-quality end product. This consistency enhances the reliability of MCC in applications requiring precise formulations, thus driving growth in this segment.

Versatility is likely to propel the non-wood-based microcrystalline cellulose (MCC) segment in the microcrystalline cellulose market. This segment benefits from the ability to source MCC from various alternative raw materials, such as agricultural residues and non-wood plants, which can offer unique properties and functionalities tailored to specific applications in food, pharmaceuticals, and cosmetics. The growing demand for sustainable and eco-friendly products is driving manufacturers to seek alternatives to traditional wood-based sources, which are often associated with deforestation and environmental concerns.

Will Innovative Drug Development Boost the Pharmaceuticals Segment for the Microcrystalline Cellulose Market?

The pharmaceutical segment is dominating the microcrystalline cellulose market. Innovative drug development is expected to significantly promote the pharmaceuticals segment of the microcrystalline cellulose (MCC) market. As pharmaceutical companies pursue novel drug formulations and delivery systems, MCC's unique properties-such as its ability to enhance tablet disintegration, improve drug solubility, and act as a binding agent-make it a crucial excipient in formulation processes. The rise of personalized medicine and the need for more efficient drug delivery systems are driving demand for MCC, as it can be tailored to meet the specific requirements of various drug formulations.

The growing demand for pharmaceuticals will significantly promote the microcrystalline cellulose (MCC) segment within the microcrystalline cellulose market. MCC is widely used as an excipient in drug formulations due to its excellent binding, disintegrating, and flow properties, which enhance the efficiency and stability of pharmaceutical products. The increasing prevalence of chronic diseases and the subsequent rise in the need for effective medications are driving pharmaceutical companies to develop new formulations, thereby boosting the demand for high-quality excipients like MCC.

Country/Region-wise Acumens

Will the Increasing Pharmaceutical Industry Accelerate the North American Region for Microcrystalline Cellulose Market?

North America's dominance in the microcrystalline cellulose market. The growing pharmaceutical industry is set to accelerate the microcrystalline cellulose (MCC) market in North America. This region currently dominates the global MCC market, largely due to its strong pharmaceutical sector, which relies heavily on MCC as an excipient in drug formulations. The consistent increase in new drug approvals by the U.S. Food and Drug Administration (FDA)-with 59 in 2018, 48 in 2019, and 53 in 2020-highlights the expanding pharmaceutical landscape and directly drives the demand for MCC. The rising preference for processed foods in North America further contributes to the sustained growth of the MCC market, reinforcing the region's leadership in this industry.

The expansion of the food and beverage industry will accelerate the Microcrystalline Cellulose (MCC) market in North America. The U.S. Department of Agriculture (USDA) highlights that the food processing industry constitutes 16% of the nation's manufacturing sector value, indicating its substantial role in the economy. As consumers increasingly prioritize healthier and more convenient food options, the demand for MCC has surged, particularly as a fat replacer and stabilizer in low-fat products.

Will the Growing Food and Beverage Industry Lead the Asian Pacific Region for Microcrystalline Cellulose Market?

Asia Pacific is rapidly growing in the microcrystalline cellulose market. The growing food and beverage industry is expected to escalate the microcrystalline cellulose (MCC) market in the Asia Pacific region. According to the United Nations Food and Agriculture Organization (FAO), the region is projected to account for 39% of the global food market by 2030, highlighting its significance in the global food landscape. As health consciousness rises among Asian consumers, the demand for MCC as a stabilizer, texturizer, and fat replacer in low-calorie foods aligns perfectly with this trend.

The growing population in the Asia Pacific region will escalate the Microcrystalline Cellulose (MCC) market. The United Nations projects that Asia's population will rise to 5.2 billion by 2050, up from 4.7 billion in 2020, creating a substantial demand for food and pharmaceutical products. This population growth, combined with increasing disposable incomes, is expected to lead to higher consumption of processed foods and pharmaceuticals, where MCC is widely used as an excipient, binder, and stabilizer. As more consumers seek convenient and health-oriented products, the demand for MCC will continue to strengthen, driving market expansion in the region.

Competitive Landscape

The Microcrystalline Cellulose Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the market include:

• FMC Corporation
• DuPont de Nemours, Inc.,
• Mingtai Chemical Co., Ltd.
• Asahi Kasei Corporation
• JRS Pharma
• Sigachi Industries
• BNF
• Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
• HPMC
• Medgel

Latest Developments

• In December 2022, JRS PHARMA (J. RETTENMAIER & SOHNE GmbH + Co KG) revealed plans to build a new manufacturing plant in Cedar Rapids, Iowa. The facility, a two-story pre-cast building, will start construction in fall 2022 and begin operations in early 2024, producing Microcrystalline Cellulose products.
• In September 2022, Roquette Freres S.A., a renowned global provider of plant-based ingredients and a top supplier of pharmaceutical and nutraceutical excipients, announced the full acquisition of Crest Cellulose, an excipient manufacturer based in India.

Microcrystalline Cellulose Market, By Category

• Source Type:
• Non-wood-based MCC
• Wood-based MCC
• Application:
• Cosmetics and Personal Care
• Food and Beverages
• Pharmaceuticals
• End User:
• Cosmetics and Personal Care Industry
• Food and Beverage Industry
• Pharmaceutical Industry
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4.Microcrystalline Cellulose Market, By Source Type

• Non-wood-based MCC
• Wood-based MCC

5. Microcrystalline Cellulose Market, By Application

• Cosmetics and Personal Care
• Food and Beverages
• Pharmaceuticals

6. Microcrystalline Cellulose Market, By End User

• Cosmetics and Personal Care Industry
• Food and Beverage Industry
• Pharmaceutical Industry

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Wei Ming Pharmaceutical Co., Ltd. (China)
• Juku Orchem Private Limited (India)
• Sigachi (Japan)
• BLANVER (China)
• Anhui Sunhere Pharmaceutical Group Co., Ltd. (China)
• Roquette Freres (France)
• DuPont de Nemours, Inc. (US)
• Ashland Global Holdings Inc. (US)
• Borregaard ASA (Norway)
• Imerys S.A. (France)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References